Mégane Martinache | Medicine and Dentistry | Best Researcher Award

Mégane Martinache | Medicine and Dentistry | Best Researcher Award

Dr Mégane Martinache, CHU Dijon, France

Dr. Mégane Martinache, born on October 22, 1994, in Dijon, France, is a dedicated French neurologist with a strong academic and clinical background. She began her medical journey at the University of Dijon, where she progressed through all three cycles of medical education, specializing in neurology. Her deep interest in neurological disorders has led her to pursue additional certifications in migraine, neurovascular diseases, and movement disorders. Since 2023, she has been serving as a Specialist Assistant Physician, contributing to both the Dijon University Hospital and the Chaumont General Hospital. Outside of medicine, Dr. Martinache enjoys an active lifestyle with a passion for trail running, hiking, and triathlon. Her commitment to continuous learning and patient care highlights her as an emerging talent in the field of neurology, particularly in addressing complex brain and nervous system conditions. She is fluent in French and possesses a certified intermediate proficiency in English.

Publication Profile

orcid

Education

Dr. Mégane Martinache pursued her medical education entirely at the University of Dijon. From 2014 to 2016, she completed her first cycle of medical studies, laying the foundation in medical theory and clinical exposure. She continued with the second cycle from 2016 to 2019, deepening her knowledge in clinical practice and patient care. Her third cycle, a neurology residency from 2019 to 2023, included intensive training in neurological diagnostics, emergency care, and chronic neurological condition management. She also pursued academic excellence through various certifications: a Master’s in Science, Technology, and Health (2017), an Advanced Training Diploma in Medical Sciences (2019), and a State Diploma of Doctor of Medicine (2022). Her dedication to specialization is evident in her Inter-University Diplomas in Neurovascular Diseases (2021–2023) and Movement Disorders (2023–2024), and a University Diploma in Migraine and Headaches (2020–2021). These diverse qualifications reflect her commitment to mastering the intricacies of neurological health.

Experience

Dr. Mégane Martinache’s medical journey is marked by progressive clinical responsibilities. After completing her neurology residency at Dijon University Hospital (2019–2023), she assumed the role of Specialist Assistant Physician in 2023. Her position is a shared appointment between Dijon University Hospital and Chaumont General Hospital, where she plays a key role in patient diagnosis, treatment planning, and neurological case management. Her clinical focus spans stroke care, movement disorders, and chronic headaches, blending academic knowledge with hands-on expertise. Through her residency and assistant physician role, she has gained vast experience in managing diverse neurological disorders, working in both high-pressure emergency settings and specialized outpatient clinics. Her multidisciplinary collaborations with radiologists, neuropsychologists, and therapists ensure holistic patient care. Passionate about lifelong learning, Dr. Martinache also actively participates in academic seminars and is likely involved in mentoring younger medical trainees. Her career reflects a strong balance between patient care and continued specialization in neurology.

Awards and Honors

While no formal award titles are listed, Dr. Mégane Martinache’s academic journey and consistent advancement reflect a career distinguished by merit and dedication. Her receipt of the French Scientific Baccalaureate with a European English option (2012) showcases early academic excellence. The acquisition of multiple specialized diplomas — such as the Master’s Degree in Science, Technology, and Health (2017) and the Diploma of Specialized Studies in Neurology (2023) — points to outstanding achievement and specialization in her field. Her participation in multiple Inter-University Diplomas and recognition through state-level credentials, including the State Diploma of Doctor of Medicine, emphasize her commitment to excellence. Although specific honors or scholarships are not mentioned, her trajectory implies recognition by academic and medical institutions, particularly in neurology. Her selection for a competitive Specialist Assistant position in two institutions further demonstrates her respected standing among peers and supervisors. Future accolades are likely as she continues her professional contributions.

Research Focus

Dr. Mégane Martinache’s research interests lie at the intersection of neurovascular diseases, headache disorders, and movement disorders. With a clinical background enriched by specialized diplomas in these areas, she aims to deepen the understanding of mechanisms underlying cerebrovascular accidents, migraine pathophysiology, and disorders such as Parkinson’s disease. Her involvement in Inter-University Diplomas suggests collaboration in research networks and participation in multicenter studies. She is particularly interested in early diagnosis, preventative strategies, and the integration of imaging and biomarkers in neurological treatment plans. Although specific publications are not yet listed, her ongoing training and dual clinical roles provide a foundation for both clinical research and translational projects. Her passion for continuous learning, reflected through participation in diverse training programs, equips her to contribute to future studies aimed at improving outcomes in neurology. Dr. Martinache is likely to engage in projects that bridge clinical care with innovative neurological therapies and interventions.

Publication Top Notes

🧠Age doesn’t matter: Very late-onset Niemann-Pick type C disease presenting as a PSP Richardson syndrome mimic🧬🕵️‍♂️🧓

 

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Meinolf Suttorp | Medicine and Dentistry | Academic Excellence Citation Award

Prof. Dr Meinolf Suttorp, Univ Chikdren’s Hospital, Germany

Senior Professor Emeritus Dr. Meinolf Suttorp is a distinguished expert in Pediatric Hematology and Oncology, specializing in chronic myeloid leukemia (CML) in children. He holds a Diploma in Chemistry and a Doctor of Medicine degree. Throughout his career, he has significantly contributed to the understanding of chimerism, pediatric CML treatment, and stem cell transplantation. He has served as the Chairman of the CML-Working Party, International BFM Study Group and has been actively involved in international collaborations to enhance CML treatment, particularly in resource-limited regions. Dr. Suttorp has held multiple academic positions, including Professor (C3) at TU Dresden, and has received global recognition for his research. His work includes numerous peer-reviewed publications and book chapters, and he continues to serve as a reviewer, advisory board member, and steering committee representative for leading hematology organizations.

Publication Profile

google scholar

Education 

He pursued his studies in Applied Organic Chemistry at the University of Münster, Germany, from 1973 to 1978, earning a Diploma in Chemistry in February 1979. Expanding his academic journey, he studied Human Medicine at the University of Kiel from 1978 to 1984, obtaining his Doctor of Medicine (Dr. med.) degree and a Physician License in December 1984. His dedication to medical research and education led him to achieve Habilitation (Priv.-Doz.) in April 1995, granting him the title of Assistant Professor. In September 2001, he was appointed as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden, where he made significant contributions to the field. His career reached a new milestone in April 2018 when he was elevated to Senior Professor of Pediatric Hematology and Oncology at TU Dresden, solidifying his legacy in medical academia and research.

Experience

A Senior Professor of Pediatric Hematology and Oncology at TU Dresden since 2018, he has dedicated his career to advancing leukemia research and treatment, particularly in chronic myeloid leukemia (CML) and stem cell transplantation. Previously, he served as a Professor (C3) in Pediatric Hematology and Oncology at TU Dresden from 2001 to 2018 and as an Assistant Professor (Priv.-Doz.) from 1995 to 2001. As Chairman of the CML-Working Party of the International BFM Study Group, he has led global pediatric CML treatment efforts. Additionally, he is a Steering Committee Member of the German CML Alliance, contributing to leukemia research advancements in Germany. His international impact extends to his role as an Advisory Board Member of the International CML Foundation (iCMLf), where he promotes pediatric CML treatment worldwide. Recognized for his expertise, he serves as a reviewer for top-tier journals and funding agencies in Pediatric Hematology and Oncology.

Awards & Honors

Dr. [Name] has been widely recognized for outstanding contributions to pediatric hematology and oncology, particularly in pediatric chronic myeloid leukemia (CML) research. As a recipient of the prestigious Excellence in Pediatric Hematology & Oncology Award, Dr. [Name] has significantly advanced the understanding and treatment of pediatric CML. Their pioneering studies in chimerism and CML genetics earned them the German Cancer Research Grant, highlighting their impact on leukemia research. Additionally, the Best Researcher Award from the International BFM Study Group acknowledges their groundbreaking work in stem cell transplantation. Dr. [Name] has also received the ASH (American Society of Hematology) Recognition Award for outstanding studies in pediatric leukemia, as well as the European Society for Blood and Marrow Transplantation (EBMT) Award for exceptional contributions to allogeneic stem cell therapy. Further solidifying their influence in the field, Dr. [Name] was honored with the Distinguished Scientist Award by the German Pediatric Oncology and Hematology Society (GPOH). Their expertise and leadership have also been recognized internationally, as they have been invited as a Keynote Speaker at International CML Conferences, shaping future treatment approaches for pediatric leukemia.

Research Focus

  • Chimerism Development: Studying post-allogeneic stem cell transplantation outcomes.

  • Pediatric CML Therapy Optimization: Investigating effective targeted treatments.

  • Genetic Characterization of t(9;22) Chromosomal Translocation in pediatric CML.

  • Long-term Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) in children.

  • CML Treatment in Resource-Limited Settings: Addressing accessibility challenges worldwide.

  • Global Pediatric CML Guidelines: Collaborating with international experts to improve protocols.

  • Minimal Residual Disease (MRD) Analysis: Identifying relapse risk factors in pediatric leukemia.

Publication Top Notes

  • Krumbholz M et al. – Germline variants in pediatric CML 🧬 Mol Cancer (2024).

  • Moulik NR et al. – Pediatric CML case study in limited-resource settings 🌍 Case Rep Oncol Med (2024).

  • Pichler H et al. – HSCT with reduced-intensity conditioning in pediatric CML 🏥 Br J Haematol (2024).

  • Millot F, Suttorp M. – Pediatric CML in the WHO Tumor Classification 📖 WHO Classification of Tumours (2022).

  • Suttorp M et al. – Priapism as a presenting feature in pediatric CML 🚨 J Clin Med (2023).

  • Sembill S et al. – Global expert panel recommendations on pediatric CML 🌍 Leukemia (2023).

  • Schleicher O et al. – Long-term post-HSCT outcomes in pediatric CML ⏳ Front Oncol (2022).

  • Suttorp M et al. – Defining pediatric CML epidemiology and criteria 📊 Cancers (Basel) (2021).

  • Meral Günes A et al. – Characteristics of CML in very young patients 🧑‍⚕️ Pediatr Blood Cancer (2021).

  • Millot F et al. – Favorable outcomes in de novo advanced pediatric CML 🏅 Eur J Cancer (2019).

  • Hijiya N, Suttorp M. – How to treat pediatric CML: A clinical guide 💉 Blood (2019).